Momordin Ic (CAS No 96990-18-0) is a bioactive compound primarily studied in the field of biomedical research for its therapeutic potential This triterpenoid saponin is derived from the fruit of the bitter melon plant Momordica charantia and is known for its diverse biological activities The mechanism of action involves multiple pathways including the modulation of apoptotic and inflammatory processes leading to potential antitumor and anti-inflammatory effects In vitro studies often demonstrate activity in the nanomolar to low micromolar range indicating its potency Its typical applications include research using various cancer cell models and animal studies to explore its efficacy as an anticancer agent Momordin Ic is also utilized in drug screening assays to uncover novel therapeutic strategies Experimental concentrations typically depend on the specific research design providing flexibility in various study setups